In situ-gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide

Nose-to-brain delivery of antipsychotics using nanotechnology: a review

(2020) Madeleine S. A. Tan et al.   Expert Opinion on Drug Delivery

In Vitro Biocompatibility Evaluation of Nine Dermal Fillers on L929 Cell Line

(2020) Vincenza Cannella et al.   Biomed Research International

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson’s disease

(2019) Sebastiaan P. van Kessel et al.   Nature Communications

Nose-to-brain peptide delivery – The potential of nanotechnology

(2018) Eleni Samaridou et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

(2018) Mukta Agrawal et al.   JOURNAL OF CONTROLLED RELEASE

Starch-Chitosan Polyplexes: A Versatile Carrier System for Anti-Infectives and Gene Delivery

(2018) Hanzey Yasar et al.   Polymers

Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

(2018) Fabio Sonvico et al.   Pharmaceutics

Molecular structure, functionality and applications of oxidized starches: A review

(2017) Nathan Levien Vanier et al.   FOOD CHEMISTRY

Intranasal delivery of antipsychotic drugs

(2017) Yogesh K. Katare et al.   SCHIZOPHRENIA RESEARCH

Characterization and Drug Delivery Properties of OSA Starch-Based Nanoparticles Prepared in [C3OHmim]Ac-in-Oil Microemulsions System

(2017) Liang Qi et al.   ACS Sustainable Chemistry & Engineering

Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy

(2016) Noriyasu Kamei et al.   MOLECULAR PHARMACEUTICS

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

(2015) M. Elizabeth Meredith et al.   AAPS Journal

Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA

(2015) Dipannita Basu et al.   PEPTIDES

The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010

(2015) Harvey A. Whiteford et al.   PLoS One

Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)–block-poly(d,l)-lactic-co-glycolic acid (PEG–PLGA) nanoparticles for the treatment of schizophrenia

(2014) Justin Piazza et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Emerging drugs for schizophrenia: an update

(2014) Luisa-Sophie Köster et al.   EXPERT OPINION ON EMERGING DRUGS

Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

(2014) Sutapa Barua et al.   Nano Today

Bitopertin

(2014) Donald C. Goff   JAMA Psychiatry

Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic–ischemic brain injury

(2013) Dianer Yang et al.   EXPERIMENTAL NEUROLOGY

Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia

(2013) Mattea L. Tan et al.   PEPTIDES

Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization

(2013) Dipannita Basu et al.   PLoS One

Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care

(2013) Wai Tong Chien et al.   Neuropsychiatric Disease and Treatment

PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia

(2012) Michael G.R. Beyaert et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Intranasal administration of PACAP: Uptake by brain and regional brain targeting with cyclodextrins

(2012) Naoko Nonaka et al.   PEPTIDES

Intranasal drug delivery: An efficient and non-invasive route for systemic administration

(2012) Stanislas Grassin-Delyle et al.   PHARMACOLOGY & THERAPEUTICS

Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery

(2012) Sveinbjorn Gizurarson   Current Drug Delivery

Intranasal delivery of biologics to the central nervous system

(2011) Jeffrey J. Lochhead et al.   ADVANCED DRUG DELIVERY REVIEWS

Preparation of highly cross-linked, monodisperse poly(methyl methacrylate) microspheres by dispersion polymerization; Part II. Semi-continuous processes

(2011) Ki-Chang Lee et al.   MACROMOLECULAR RESEARCH

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

(2010) Joanna C. Neill et al.   PHARMACOLOGY & THERAPEUTICS

Insight on the periodate oxidation of dextran and its structural vicissitudes

(2010) João Maia et al.   POLYMER

PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: Implications for the treatment of negative symptoms in schizophrenia

(2010) Bailee Dyck et al.   SCHIZOPHRENIA RESEARCH

UV induced cross-linking of starch modified with glycidyl methacrylate

(2009) Jesper Hedin et al.   CARBOHYDRATE POLYMERS

Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*

(2009) J. Karagianis et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Creation of a standardized geometry of the human nasal cavity

(2009) Y. Liu et al.   JOURNAL OF APPLIED PHYSIOLOGY

Respiratory delivery of theophylline by size-targeted starch microspheres for treatment of asthma

(2009) Arash Momeni et al.   JOURNAL OF MICROENCAPSULATION

Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality

(2008) J. McGrath et al.   EPIDEMIOLOGIC REVIEWS

Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier

(2008) Akhlesh Kumar Jain et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS